鳥居薬品の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2021/04/19 | 2,909 | 2,930 | 2,868 | 2,882 | -23 | -0.8% | 22,000 |
| 2021/04/16 | 2,853 | 2,906 | 2,849 | 2,905 | +51 | +1.8% | 36,500 |
| 2021/04/15 | 2,840 | 2,873 | 2,840 | 2,854 | +20 | +0.7% | 22,300 |
| 2021/04/14 | 2,866 | 2,879 | 2,812 | 2,834 | -50 | -1.7% | 62,100 |
| 2021/04/13 | 2,861 | 2,906 | 2,858 | 2,884 | +13 | +0.5% | 29,600 |
| 2021/04/12 | 2,898 | 2,920 | 2,865 | 2,871 | -12 | -0.4% | 17,400 |
| 2021/04/09 | 2,876 | 2,906 | 2,853 | 2,883 | -3 | -0.1% | 35,400 |
| 2021/04/08 | 2,906 | 2,925 | 2,886 | 2,886 | -33 | -1.1% | 42,400 |
| 2021/04/07 | 2,903 | 2,932 | 2,897 | 2,919 | -1 | ±0% | 29,500 |
| 2021/04/06 | 2,935 | 2,943 | 2,903 | 2,920 | -15 | -0.5% | 37,200 |
| 2021/04/05 | 2,930 | 2,966 | 2,930 | 2,935 | -15 | -0.5% | 16,700 |
| 2021/04/02 | 2,962 | 2,980 | 2,928 | 2,950 | -38 | -1.3% | 60,300 |
| 2021/04/01 | 3,000 | 3,050 | 2,975 | 2,988 | -12 | -0.4% | 40,000 |
| 2021/03/31 | 2,975 | 3,020 | 2,921 | 3,000 | -20 | -0.7% | 70,500 |
| 2021/03/30 | 2,987 | 3,045 | 2,970 | 3,020 | +51 | +1.7% | 71,400 |
| 2021/03/29 | 3,110 | 3,110 | 2,931 | 2,969 | -131 | -4.2% | 146,700 |
| 2021/03/26 | 3,070 | 3,115 | 3,040 | 3,100 | +45 | +1.5% | 54,500 |
| 2021/03/25 | 3,020 | 3,075 | 2,985 | 3,055 | +57 | +1.9% | 37,900 |
| 2021/03/24 | 3,100 | 3,100 | 2,963 | 2,998 | -82 | -2.7% | 60,700 |
| 2021/03/23 | 3,150 | 3,150 | 3,060 | 3,080 | -70 | -2.2% | 33,900 |
| 2021/03/22 | 3,100 | 3,160 | 3,090 | 3,150 | ±0 | ±0% | 41,500 |
| 2021/03/19 | 3,140 | 3,195 | 3,115 | 3,150 | +20 | +0.6% | 59,200 |
| 2021/03/18 | 3,120 | 3,135 | 3,105 | 3,130 | +10 | +0.3% | 46,700 |
| 2021/03/17 | 3,140 | 3,155 | 3,100 | 3,120 | -90 | -2.8% | 28,500 |
| 2021/03/16 | 3,140 | 3,215 | 3,135 | 3,210 | +90 | +2.9% | 53,500 |
| 2021/03/15 | 3,070 | 3,125 | 3,070 | 3,120 | +90 | +3% | 53,100 |
| 2021/03/12 | 3,085 | 3,085 | 3,015 | 3,030 | -70 | -2.3% | 42,400 |
| 2021/03/11 | 3,040 | 3,105 | 2,988 | 3,100 | +113 | +3.8% | 47,200 |
| 2021/03/10 | 3,025 | 3,025 | 2,965 | 2,987 | -13 | -0.4% | 35,100 |
| 2021/03/09 | 2,992 | 3,010 | 2,969 | 3,000 | +28 | +0.9% | 25,500 |
| 2021/03/08 | 2,957 | 2,982 | 2,946 | 2,972 | +28 | +1% | 36,100 |
| 2021/03/05 | 2,926 | 2,953 | 2,872 | 2,944 | +28 | +1% | 47,700 |
| 2021/03/04 | 2,960 | 2,960 | 2,880 | 2,916 | -44 | -1.5% | 33,000 |
| 2021/03/03 | 3,000 | 3,015 | 2,949 | 2,960 | -45 | -1.5% | 32,600 |
| 2021/03/02 | 3,015 | 3,030 | 2,985 | 3,005 | -25 | -0.8% | 48,200 |
| 2021/03/01 | 2,997 | 3,060 | 2,997 | 3,030 | +33 | +1.1% | 26,900 |
| 2021/02/26 | 3,105 | 3,105 | 2,997 | 2,997 | -98 | -3.2% | 58,000 |
| 2021/02/25 | 3,120 | 3,160 | 3,090 | 3,095 | +15 | +0.5% | 47,500 |
| 2021/02/24 | 3,010 | 3,130 | 2,997 | 3,080 | +75 | +2.5% | 81,300 |
| 2021/02/22 | 3,000 | 3,030 | 2,976 | 3,005 | -5 | -0.2% | 43,200 |
| 2021/02/19 | 2,981 | 3,010 | 2,981 | 3,010 | +10 | +0.3% | 39,900 |
| 2021/02/18 | 3,040 | 3,040 | 2,976 | 3,000 | -55 | -1.8% | 47,500 |
| 2021/02/17 | 3,010 | 3,060 | 3,010 | 3,055 | +25 | +0.8% | 16,600 |
| 2021/02/16 | 3,030 | 3,040 | 2,998 | 3,030 | -20 | -0.7% | 33,000 |
| 2021/02/15 | 3,050 | 3,055 | 3,025 | 3,050 | +15 | +0.5% | 23,600 |
| 2021/02/12 | 3,040 | 3,060 | 3,020 | 3,035 | -30 | -1% | 39,700 |
| 2021/02/10 | 3,105 | 3,115 | 3,045 | 3,065 | -65 | -2.1% | 51,800 |
| 2021/02/09 | 3,175 | 3,175 | 3,085 | 3,130 | -45 | -1.4% | 82,100 |
| 2021/02/08 | 3,155 | 3,185 | 3,130 | 3,175 | +35 | +1.1% | 27,700 |
| 2021/02/05 | 3,185 | 3,200 | 3,060 | 3,140 | -75 | -2.3% | 56,800 |
1001～
1050
件表示中 / 3705件
類似銘柄と比較する
現在ご覧いただいている「鳥居薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 鳥居薬 | 633,000円 | +7.1% | -35.0% | 0.00% | 52.34倍 | 1.46倍 |
|
ＪＴ傘下。柱の抗ＨＩＶ薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
| ペプチド | 167,300円 | +5.0% | +1.5% | 0.00% | 14.31倍 | 3.81倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
| キッセイ薬 | 385,500円 | +3.6% | +6.1% | 3.11% | 12.99倍 | 0.76倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
| 科研薬 | 373,800円 | -6.4% | -71.8% | 5.08% | 41.63倍 | 0.93倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の２本柱。後発品も展開 |
| 東和薬品 | 299,500円 | +7.9% | -3.3% | 2.67% | 8.33倍 | 0.86倍 |
|
後発医薬品メーカーで国内２強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
市場注目の銘柄
チャート関連のコラム
